Tranexamic Acid Clinical Research

November 05, 2012 02:03 PM EST By: Jennifer Rocha

Department of Defense: Army Deadline: January 28, 2013

The DoD seeks prospective clinical studies examining the effects of tranexamic acid in the treatment of patients with traumatic hemorrhage. The Combat Casualty Care Research Program provides resources for advances in biotechnology research administered by the Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, Maryland. With this Program Announcement/Funding Opportunity, the US Army Medical Research and Materiel Command (USAMRMC) is seeking to fund biotechnology research that culminates in outcomes and technologies that may qualify as advanced development activities within the Department of Defense (DoD).

For more information, visit:;jsessionid=GVQNQJLQJs5cJdypsN6B5zGkLxTvDJbyZxJC8b8N4KSR3mFlcZwC!1776773140?oppId=205553&mode=VIEW


  Subscribe to our mailing list, and we'll keep you posted of the latest developments.

RSS feed of TechConnect News™ RSS feed of TechConnect News™